Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome

Leuk Res. 2009 Feb;33(2):340-3. doi: 10.1016/j.leukres.2008.07.005. Epub 2008 Aug 8.

Abstract

Bone marrow aspirates of 19 patients with low-risk myelodysplastic syndromes (MDS) and 14 control subjects were collected in order to assess the level of oxidative DNA damage. Glycophorin A positive and negative cells separated by miniMACS magnetic cell sorting were subjected to single cell gel electrophoresis (comet assay) combined with enzymes of base excision repair (endonuclease III and formamido-pyrimidine-glycosylase) that specifically recognize oxidized nucleotides. Compared to controls, MDS patients exhibited a significant increase of oxidative damage to DNA which could contribute to genomic instability and disease progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anemia, Refractory
  • Anemia, Refractory, with Excess of Blasts
  • Bone Marrow Cells / pathology*
  • Case-Control Studies
  • Comet Assay
  • DNA Damage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / pathology*
  • Oxidative Stress